Is there a generic for Sodium chromate cr-51?

The FDA Orange Book does not currently list an approved generic (ANDA) for Sodium chromate cr-51. It is available as 2 brand (NDA) applications.

What is the reference-listed drug for Sodium chromate cr-51?

CHROMITOPE SODIUM (NDA 013993, BRACCO) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Sodium chromate cr-51 are approved?

Sodium chromate cr-51 is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Sodium chromate cr-51

Sodium chromate cr-51 is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:CHROMITOPE SODIUM · NDA 013993

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
CHROMITOPE SODIUM×2	BRACCO	NDA 013993	—	Approved Prior to Jan 1, 1982
SODIUM CHROMATE CR 51	CURIUM	NDA 016708	—	Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Sodium chromate cr-51 — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo